Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Rasmus Ehren's publication output changed over time?
ScholarIQpublication output · 2015–2023
Output grew100% over the shown period — from 1 works in 2015 to 2 in 2023.
1
1
1
4
2
2
201520162017202020212023
What are the most-cited papers on Rasmus Ehren?
ScholarIQmost cited works
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome
Oliver Groß, Burkhard Tönshoff, Lutz T. Weber, Lars Pape, Kay Latta, Henry Fehrenbach, Baerbel Lange‐Sperandio, H. Zappel, Peter F. Hoyer, Hagen Staude, Sabine König, Ulrike John, Jutta Gellermann, Bernd Höppe, Matthias Galiano, Britta Hoecker, Rasmus Ehren, Christian Lerch, Clifford E. Kashtan, Markus Harden, Jan Boeckhaus, Tim Friede, Michael Koziolek, Carsten Bramlage, Frauke Weber, Tanja Albrecht-Nock, Joseph Sonntag, Jenny Frese, Matthias Kettwig, Reinhard Hilgers, Matthias Hansen, Mirja Wedekin, Nicole Meyer, S. Klaiber, Michaela Geßner, Max C. Liebau, Anne-Kristin Vogt-Weigeldt, Therese Jungraithmayr, Sabine Ponsel, Ulrike Jacoby, Martin Konrad, Brigitta Kranz, Jens Koenig, Lisa Loechtermann, Michael Pohl, Ralf A. Husain, Katrin Mueller, Julia Thumfart, Gesa Schalk, Markus Feldkoetter, Sabine Schmidt, Katja Sauerstein, Evelin Muschiol, Heiko Billing, Frauke Wilkening
Kidney International. 2020158 CitationsOPEN ACCESS
Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome
Ágnes Hackl, Orsolya Cseprekál, Michaela Geßner, Max C. Liebau, Sandra Habbig, Rasmus Ehren, Carsten Müller, Christina Taylan, Jörg Dötsch, Lutz T. Weber
Therapeutic Drug Monitoring. 201552 Citations
The role of the immune system in idiopathic nephrotic syndrome
Ágnes Hackl, Seif El Din Abo Zed, Paul Diefenhardt, Julia Binz-Lotter, Rasmus Ehren, Lutz T. Weber
Molecular and Cellular Pediatrics. 202137 CitationsOPEN ACCESS
A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants
Georgia Malakasioti, Daniela Iancu, Anastasiia Milovanova, А.Н. Цыгин, Tomoko Horinouchi, China Nagano, Kandai Nozu, Koichi Kamei, Shuichiro Fujinaga, Kazumoto Iijima, Hee Gyung Kang, Rajiv Sinha, Biswanath Basu, William Morello, Giovanni Montini, Aoife Waters, Olivia Boyer, Zeynep Yürük Yıldırım, Sibel Yel, İsmail Dursun, Hugh J. McCarthy, Marina Vivarelli, Larisa Prikhodina, Martine Besouw, Eugene Yu-hin Chan, Wenyan Huang, Markus J. Kemper, Sebastian Loos, Chanel Prestidge, William Wong, Galia Zlatanova, Rasmus Ehren, Lutz T. Weber, Hassib Chehade, Nakysa Hooman, Marcin Tkaczyk, Małgorzata Stańczyk, Michael Miligkos, Kjell Tullus
Kidney International. 202336 CitationsOPEN ACCESS
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020
Rasmus Ehren, Marcus R. Benz, Paul Brinkkötter, Jörg Dötsch, W. Eberl, Jutta Gellermann, Peter F. Hoyer, Isabelle Jordans, Clemens Kamrath, Markus J. Kemper, Kay Latta, Dominik Müller, Jun Oh, Burkhard Tönshoff, Stefanie Weber, Lutz T. Weber, on behalf of the German Society for Pediatric Nephrology
Pediatric Nephrology. 202134 CitationsOPEN ACCESS
Related on ScholarIQ
University of Cologne
Institution
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome
Paper
Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome
Paper
The role of the immune system in idiopathic nephrotic syndrome
Paper
A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants
Paper
Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy —short version of the updated German best practice guideline (S2e) — AWMF register no. 166-001, 6/2020
Paper